Human Integrin beta 2/CD18 Alexa Fluor® 350-conjugated Antibody
R&D Systems, part of Bio-Techne | Catalog # FAB1730U
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Gln23-Asn700
Accession # AAA59490
Specificity
Clonality
Host
Isotype
Applications for Human Integrin beta 2/CD18 Alexa Fluor® 350-conjugated Antibody
Flow Cytometry
Sample: Human peripheral blood mononuclear cells
Formulation, Preparation, and Storage
Purification
Formulation
Shipping
Stability & Storage
Background: Integrin beta 2/CD18
Integrin alphaX beta2, also called CD11c/CD18, p150/95 or complement receptor type 4 (CR4), is one of four beta2 integrins. The non-covalent heterodimer of 150 kDa alphaX/CD11c and 95 kDa beta2/CD18 integrin subunits is expressed on macrophages, dendritic cells and hairy cell leukemias, with lower amounts on other myeloid cells and activated B, NK and some cytotoxic T cells (1‑7). Like other integrins, alphaX beta2 has multiple activation states (3). In the presence of divalent cations and "inside-out" signaling, alphaX beta2 is fully active and extended. The alphaX vWFA or I-domain, which contains the adhesion sites, forms the N-terminal head region with the alphaX beta-propeller and the beta2 vWFA domain (1, 8). In the inactive state, the heterodimer flexes in the center at the alphaX thigh and calf domains and beta2 I-EGF domains, impeding access to adhesion sites (1). The 1088 aa human alphaX/CD11c ECD shares 70‑76% aa sequence identity with mouse, rat and canine alphaX while the 678 aa human beta2/CD18 ECD shares 81‑83% aa sequence identity with mouse, rat, cow, dog, goat, sheep, and pig beta2. Potential alphaX isoforms containing 719 and 725 aa (as compared to full-length 1163 aa alphaX) lack the vWFA domain and the N-terminus. Active alphaX beta2 shares some adhesion partners with alphaM beta2/CD11b/CD18, including complement opsonin fragment iC3b, ICAMs, vWF and fibrinogen, and is expressed on many of the same cells (4‑11). However, alphaM beta2 activity is often constitutive, while alphaX beta2 activity requires cell activation (4‑7). alphaX beta2 also binds osteopontin, Thy-1, plasminogen, heparin, and proteins with abnormally exposed acidic residues (11‑16). The adhesion events are important for proliferation, degranulation, chemotactic migration, and phagocytosis of complement-opsonized particles (5, 6, 9, 11, 12, 16). Mutations of beta2, especially in the vWFA domain, cause leukocyte adhesion deficiency (LAD-1) and susceptibility to bacterial infections (17).
References
- Corbi, A.L. et al. (1987) EMBO J. 6:4023.
- Kishimoto, T.K. et al. (1987) Cell 48:681.
- Hynes, R.O. (2002) Cell 110:673.
- Arnaout, M.A. (1990) Blood 75:1037.
- Postigo, A.A. et al. (1991) J. Exp. Med. 174:1313.
- Beyer, M. et al. (2005) Respir. Res. 6:70.
- Nicolaou, F. et al. (2003) Blood 101:4033.
- Vorup-Jensen, T. et al. (2003) Proc. Natl. Acad. Sci. USA 100:1873.
- Bilsland, C.A.G. et al. (1994) J. Immunol. 152:4582.
- Pendu, R. et al. (2006) Blood 108:3746.
- Sadhu, C. et al. (2007) J. Leukoc. Biol. 81:1395.
- Schack, L. et al. (2009) J. Immunol. 182:6943.
- Choi, J. et al. (2005) Biochem. Biophys. Res. Commun. 331:557.
- Gang, J. et al. (2007) Mol. Cells 24:240.
- Vorup-Jensen, T. et al. (2007) J. Biol. Chem. 282:30869.
- Vorup-Jensen, T. et al. (2004) Proc. Natl. Acad. Sci. USA 102:1614.
- Kishimoto, T.K. et al. (1987) Cell 50:193.
Alternate Names
Gene Symbol
UniProt
Additional Integrin beta 2/CD18 Products
Product Documents for Human Integrin beta 2/CD18 Alexa Fluor® 350-conjugated Antibody
Product Specific Notices for Human Integrin beta 2/CD18 Alexa Fluor® 350-conjugated Antibody
This product is provided under an agreement between Life Technologies Corporation and R&D Systems, Inc, and the manufacture, use, sale or import of this product is subject to one or more US patents and corresponding non-US equivalents, owned by Life Technologies Corporation and its affiliates. The purchase of this product conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product only in research conducted by the buyer (whether the buyer is an academic or for-profit entity). The sale of this product is expressly conditioned on the buyer not using the product or its components (1) in manufacturing; (2) to provide a service, information, or data to an unaffiliated third party for payment; (3) for therapeutic, diagnostic or prophylactic purposes; (4) to resell, sell, or otherwise transfer this product or its components to any third party, or for any other commercial purpose. Life Technologies Corporation will not assert a claim against the buyer of the infringement of the above patents based on the manufacture, use or sale of a commercial product developed in research by the buyer in which this product or its components was employed, provided that neither this product nor any of its components was used in the manufacture of such product. For information on purchasing a license to this product for purposes other than research, contact Life Technologies Corporation, Cell Analysis Business Unit, Business Development, 29851 Willow Creek Road, Eugene, OR 97402, Tel: (541) 465-8300. Fax: (541) 335-0354.
For research use only